Atsuro Chiba

4.4k total citations · 1 hit paper
55 papers, 3.2k citations indexed

About

Atsuro Chiba is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Atsuro Chiba has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 23 papers in Cellular and Molecular Neuroscience and 12 papers in Molecular Biology. Recurrent topics in Atsuro Chiba's work include Peripheral Neuropathies and Disorders (28 papers), Hereditary Neurological Disorders (22 papers) and Peripheral Nerve Disorders (7 papers). Atsuro Chiba is often cited by papers focused on Peripheral Neuropathies and Disorders (28 papers), Hereditary Neurological Disorders (22 papers) and Peripheral Nerve Disorders (7 papers). Atsuro Chiba collaborates with scholars based in Japan, United States and United Kingdom. Atsuro Chiba's co-authors include Ichiro Kanazawa, Susumu Kusunoki, Teruo Shimizu, Rikuo Machinami, Ryo Obata, Richard U. Margolis, Tamao Endo, Susumu Kusunoki, Kiichiro Matsumura and Hiroki Yamada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neurology.

In The Last Decade

Atsuro Chiba

51 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum anti‐GQ _1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barre syndrome

1993 511 citations Atsuro Chiba, Susumu Kusunoki et al. profile →

Peers

Countries citing papers authored by Atsuro Chiba

Since Specialization

Citations

This map shows the geographic impact of Atsuro Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuro Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuro Chiba more than expected).

Fields of papers citing papers by Atsuro Chiba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuro Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuro Chiba. The network helps show where Atsuro Chiba may publish in the future.

Co-authorship network of co-authors of Atsuro Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuro Chiba. A scholar is included among the top collaborators of Atsuro Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuro Chiba. Atsuro Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case of polyneuropathy after COVID-19 vaccine 2022 ·Rinsho Shinkeigaku ·(unknown), Hiroki Nakayama, Hirohisa Watanabe, (unknown), Atsuro Chiba, (unknown)	0
2	Time Distortion in Parkinsonism 2021 ·Frontiers in Neuroscience ·Yasuo Terao, Motoyasu Honma, (unknown), Shin‐ichi Tokushige, Toshiaki Furubayashi, (unknown), Satomi Inomata‐Terada, (unknown), (unknown), Yaeko Ichikawa, Atsuro Chiba, Yoshikazu Ugawa, Masahiko Suzuki	10
3	Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review 2021 ·Neurology and Therapy ·Haruki Koike, Atsuro Chiba, Masahisa Katsuno	37
4	Inducing Cortical Plasticity to Manipulate and Consolidate Subjective Time Interval Production 2021 ·Neuromodulation Technology at the Neural Interface ·Motoyasu Honma, Shoko Saito, (unknown), Shin‐ichi Tokushige, Satomi Inomata‐Terada, Atsuro Chiba, Yasuo Terao	3
5	Cognitive-Behavioral-Based Physical Therapy for Patients with Severe Lumbar Spinal Stenosis: A Report of 38 Cases 2020 ·Shozo Yasuoka, Shunichiro Kubota, Atsuro Chiba, Masami Akai	1
6	Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome 2020 ·Journal of Neurology Neurosurgery & Psychiatry ·Yuko Yamagishi, Motoi Kuwahara, Hidekazu Suzuki, Masahiro Sonoo, Satoshi Kuwabara, Takanori Yokota, Kyoichi Nomura, Atsuro Chiba, Ryuji Kaji, Takashi Kanda, K. Kaida, Tatsuro Mutoh, Ryo Yamasaki, Hiroshi Takashima, Makoto Matsui, Kazutoshi Nishiyama, Gen Sobue, Susumu Kusunoki	8
7	Comparison of antibody reactivity in the first and second episodes of recurrent Miller Fisher syndrome 2020 ·Neurological Sciences ·(unknown), (unknown), (unknown), (unknown), Atsuro Chiba, Masaaki Saito	4
8	Novel SLC20A2 variant in a Japanese patient with idiopathic basal ganglia calcification-1 (IBGC1) associated with dopa-responsive parkinsonism 2019 ·Human Genome Variation ·Yaeko Ichikawa, Masaki Tanaka, (unknown), (unknown), Masaki Tanaka, (unknown), Jun Goto, Shoji Tsuji, Atsuro Chiba	4
9	Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report 2018 ·BMC Neurology ·(unknown), Yuki Hatanaka, Yuki Fukami, (unknown), (unknown), Hisashi Okada, (unknown), Atsuro Chiba, Satoshi Okuda	7
10	Ca2+-dependent anti-GQ1b antibody in GQ1b-seronegative Fisher syndrome and related disorders 2016 ·Journal of Neuroimmunology ·(unknown), Atsuko Gyohda, Atsuro Chiba	14
11	IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay 2016 ·Journal of Neuroimmunology ·Masato Kadoya, Kenichi Kaida, Haruki Koike, Hiroshi Takazaki, Hidenori Ogata, (unknown), Jun Shimizu, Eiichiro Nagata, Shunya Takizawa, Atsuro Chiba, Ryo Yamasaki, Jun‐ichi Kira, Gen Sobue, Katsunori Ikewaki	70
12	Interferon-gamma release assay in cerebrospinal fluid of a patient with tuberculous meningitis: A case report 2009 ·Rinsho Shinkeigaku ·(unknown), (unknown), (unknown), Atsuro Chiba	0
13	Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia 1999 ·Muscle & Nerve ·Susumu Kusunoki, Atsuro Chiba, Ichiro Kanazawa	119
14	High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated Molecule 1998 ·Journal of Biological Chemistry ·Peter Milev, Atsuro Chiba, Monika Häring, Heikki Rauvala, Melitta Schachner, Barbara Ranscht, Renée K. Margolis, Richard U. Margolis	168
15	Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome 1997 ·Brain Research ·Atsuro Chiba, Susumu Kusunoki, Hiroto Obata, Rikuo Machinami, Ichiro Kanazawa	189
16	Binding of antibodies against GM1 and GD1b in human peripheral nerve 1997 ·Muscle & Nerve ·Susumu Kusunoki, Hiromi Mashiko, (unknown), Atsuro Chiba, Masanobu Arita, Seiji Hitoshi, Ichiro Kanazawa	42
17	Experimental sensory neuropathy induced by sensitization with ganglioside GD1b 1996 ·Annals of Neurology ·Susumu Kusunoki, Jun Shimizu, Atsuro Chiba, Yoshikazu Ugawa, Seiji Hitoshi, Ichiro Kanazawa	153
18	Unique localization of fucosyl GM1 in rabbit spinal cord and peripheral nerve: Immunohistochemical study using monoclonal anti-fucosyl GM1 antibody CRD73-6 1994 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Susumu Kusunoki, Atsuro Chiba, Teruo Shimizu, (unknown)	11
19	N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome 1994 ·Annals of Neurology ·Susumu Kusunoki, Atsuro Chiba, Kazuo Kon, Susumu Ando, (unknown), (unknown), Ichiro Kanazawa	144
20	Generation of a monoclonal antibody specific for a new class of minor ganglioside antigens, GQ1bα and GT1aα: its binding to dorsal and lateral horn of human thoracic cord 1993 ·Brain Research ·Susumu Kusunoki, Atsuro Chiba, Yoshio Hirabayashi, Fumitoshi Irie, Masaharu Kotani, Ikuo Kawashima, Tadashi Tai, Yoshitaka Nagai	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact